Gland Pharma Company Description

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.

The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules.

The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastrointestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain and analgesics, respiratory, and vitamins, minerals, and nutrients; and contract development services.

The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Gland Pharma Limited

Country	India
Founded	1978
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	4,286
CEO	Shyamakant Giri

Contact Details

Address: Plot No. 11 & 84, TSIIC Phase: IV Hyderabad, 502307 India
Phone	91 84 5569 9999
Website	glandpharma.com

Stock Details

Ticker Symbol	GLAND
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE068V01023
SIC Code	2834

Key Executives

Name	Position
Shyamakant Giri	Chief Executive Officer
Srinivas Sadu	Executive Chairman
Ravi Shekhar Mitra	Chief Financial Officer
Sampath Kumar Pallerlamudi	Company Secretary and Vice-President of Compliance & CSR
Satnam Singh Loomba	Chief Operating Officer
Surinder Koul	Head of Domestic Marketing
K Raghuramachandra Rao	Head of Quality
R.V.R. Prabhakara Sastry	Senior Vice President of Research & Development
Rong Wu	Chief Financial Controller